to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Physician turned venture capitalist Drew Senyei sees education as society's great equalizer.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa; and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
William Sahlman is the Dimitri V. d'Arbeloff - Class of 1955 Professor of Business Administration at Harvard Business School. The d'Arbeloff Chair was established in 1986 to support teaching and research on the entrepreneurial process. The Chair honors the late Dimitri d'Arbeloff (HBS '55), whose entrepreneurial skills helped make Millipore Corporation a world leader in its industry. Mr. Sahlman received an A.B. degree in Economics from Princeton University, an M.B.A. from Harvard University, and a Ph.D. in Business Economics, also from Harvard. His research focuses on the investment and financing decisions made in entrepreneurial ventures at all stages in their development. Mr. Sahlman was co-chair of the Entrepreneurship and Service Management Unit from 1999 to 2002. From 1991 to 1999, he was Senior Associate Dean, Director of Publishing Activities, and chairman of the board for Harvard Business School Publishing Corporation. From 1990 to 1991, he was chairman of the Harvard University Advisory Committee on Shareholder Responsibility. He is a member of the board of directors of several private companies.
Any entrepreneur who hopes to raise capital from individual investors, so-called "angels," should be properly prepared with a presentation, business plan, list of potential angels, and outline of the opportunity his or her new venture affords. The author explains that it's also important to avoid making such mistakes as allowing investors to have too large a stake in the enterprise. That could cause problems should the company fail, he writes, in an article filled with specific tips for dealing with these financiers.
How do entrepreneurs change society? Is it through the potential of their ideas? Is it the passion that drives them? Or their ability to see opportunities where others cannot? Is it the impact and innovation of the events that come from their work? Or is it the belief that an idea can change the world?
As Senior Vice President of Hardware, Matt Hershenson brings a wealth of experience to Danger. He is responsible for Danger's hardware engineering, development and design efforts. Before co-founding Danger, Matt managed the hardware group at Mainbrace Corporation, a Windows CE systems integrator. Prior to Mainbrace Corporation, Matt served in various roles at Philips Electronics. During his tenure with the Philips Mobile Computing Group, he was responsible for the hardware of the Velo-1 handheld PC, one of the first Windows CE devices. While at Philips Semiconductors, Matt served as a systems architect, where he played an integral role in the design of numerous consumer handheld devices, including the Sharp Mobilon, Philips Nino, and the Compaq C-series. Before Philips, Matt was a hardware engineer with Catapult Entertainment, since acquired by Hearme. He was part of the team that turned the vision of multi-player gaming over the Internet into a reality. He handled all aspects of product development and design for the XBAND Video Game Modem. Matt also played a key role in the product development and design of the Apple Powerbook 150, then Apple's most affordable PowerBook computer. Matt also co-founded MOTO Development Group, a product design consultancy firm specializing in product development. MOTO aided in the design of many technical products, such as remote controls for Apple Interactive TV.
PIPES-or Private Investment in Public Equity-as a vehicle for companies to raise capital reverses the order of public filings from IPO or secondary offering. PIPES are a worthy alternative for raising public money but should be used selectively.
John Roos, CEO of Wilson Sonsini Goodrich and Rosati, has represented many major Silicon Valley companies during mergers and acquisitions, initial public offerings, strategic alliances, and joint ventures. In this lecture, he describes many of the lessons he's learned since joining the firm in 1988, including building a brand, taking risks, and the importance of integrity.
Heidi Roizen is a managing director for Mobius Venture Capital. She joined the fund in April 1999. Ms. Roizen serves as a director of AuctionDrop, Ecast, InStoreCard, MessageCast, Perpetual Entertainment, Planitax, and Reactrix. She is also a board member of the National Venture Capital Association (NVCA). Her notable prior board service includes Great Plains Software, which was acquired by Microsoft in 2001. Prior to joining Mobius Venture Capital, Ms. Roizen was a consultant to numerous technology companies, including Microsoft, Intel and Compaq. From 1996 to 1997, she was vice president of Worldwide Developer Relations for Apple Computer. Before joining Apple Computer, Ms. Roizen served for 13 years as CEO of T/Maker Company, a successful software developer and publisher. She is a past president of the Software Publishers Association and has served as a public governor of the Pacific Exchange. Ms. Roizen has been recognized as one of the 100 most influential people in the microcomputer industry by MicroTimes, Personal Computing Magazine and Upside Magazine. Ms. Roizen has a B.A. and an M.B.A. from Stanford University.
Bradmer Pharmaceuticals, an American biotech company, chose to use the Toronto Venture Exchange's Capital Pool Company Program to raise cash in the public markets. The author shares his experience making the decision to list in the CPC program and his lessons learned.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
